Integra LifeSciences-Integra's (IART) Q2 Earnings and Revenues Top, Margins Down

Revenue Discussion Tissue Technologies revenues totaled $116.4 million in the second quarter, up 5.6% year over year on a reported basis and 5.7% on an organic basis. The upside was due to the impact of high-double-digit growth in DuraSorb, mid-double-digit growth in Gentrix, along with low double-digit growth in MicroMatrix, Cytal and amniotics. Overall, adjusted operating profit were$ 0.7 million, down 95.6% year over year. Adjusted operating margin saw a 391-bps contraction year over year to 0.2%. Guidan ...